Drug Profile
AD 452
Latest Information Update: 29 Jan 2010
Price :
$50
*
At a glance
- Originator Sosei R&D
- Developer Medicines for Malaria Venture; Sosei R&D; Treague
- Class Antirheumatics; Disease-modifying antirheumatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malaria; Rheumatoid arthritis